Hovione

Hovione is a globally recognized pharmaceutical contract development and manufacturing company with extensive expertise in Active Pharmaceutical Ingredients (APIs), particle engineering, spray drying, inhalation products, and pharmaceutical process development. Founded in 1959 and headquartered in Loures, Portugal, Hovione has grown into one of the world’s leading specialists in complex pharmaceutical manufacturing technologies. The company serves innovative pharmaceutical and biotechnology companies across North America, Europe, and Asia-Pacific.

Hovione’s core capabilities include custom API manufacturing, highly potent active pharmaceutical ingredients (HPAPIs), continuous manufacturing, spray drying, amorphous solid dispersions, particle design, and inhalation drug development. Its advanced research teams work closely with customers from early-stage development through commercial-scale production, helping accelerate the delivery of complex medicines to global markets.

The company operates state-of-the-art manufacturing and research facilities in Portugal, Ireland, the United States, and China, all designed to meet stringent international regulatory standards. Hovione places strong emphasis on sustainability, innovation, digital manufacturing, and environmental responsibility while investing continuously in advanced pharmaceutical technologies. With decades of scientific expertise and a reputation for quality, Hovione has become a trusted global partner for pharmaceutical ingredient manufacturing and advanced drug development solutions.